Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

B
239
Background Incidence Rates of Guillain-Barre Syndrome in United States Older Adults at Risk of Respiratory Syncytial Virus in a Trial-Similar Real World Data Cohort

Favorite
333
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in South Korea

Favorite
332
Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies

Favorite
064
Battle of the Bisphosphonates: Global Utilization Trends for Osteoporosis between 2011 and 2022

Favorite
245
Benefit-Risk Assessment of Herbal Medicines Used During Pregnancy and Lactation: A Descriptive Study of Registered Herbal Medicines in Bulgaria

Favorite
303
Benzodiazepine receptor agonists and increased risk of sudden sensorineural hearing loss

Favorite
228
Beta-blocker-associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database

Favorite
007
Beyond external control arms: utility of real-world data in oncology regulatory applications

Favorite
CSPOT22
Biologic Drugs Use In Inflammatory Bowel Diseases: A Systematic Review And Meta-Analysis

Favorite
065
Bisphosphonates versus Denosumab: Assessing the Risk of Heart Failure in a Nationwide Retrospective Cohort Study in Taiwan

Favorite
304
Brain derived Neurotrophic factor (BDNF): A potential biomarker for seizure associated cognitive impairment in adult persons with epilepsy (PWE)

Favorite
094
Brain Imaging In United States Veterans Before and After Establishing Criteria for Use of Anti-amyloid Therapy for Treatment of Mild Cognitive Impairment and Alzheimer’s Dementia

Favorite
002
Breaking the Code: Patient Associations' Perception on Adverse Drug Reaction Reporting in Portugal

Favorite
008
Breast cancer incidence by subtypes - a Danish register-based study from 2012 to 2022.

Favorite
009
Breast cancer recurrence due to avoidable drug-drug interactions? Developing a protocol for a target trial in women with breast cancer who concurrently use tamoxifen and antidepressants

Favorite
107
Bridging the Gap and Ensuring Quality: Enhancing Real-World Data through Quality Control Implementation of an African Patient Population

Favorite
CSPOT34
Bruton's Tyrosine Kinase-Induced Musculoskeletal Disorders: A Real-World Safety Data Analysis of FAERS Database and Meta-Analysis of Randomized Controlled Trials

Favorite
BSPOT39
Building Patient Journeys for Prader-Willi Syndrome Patients: Insights from Electronic Health Records Through Natural Language Processing

Favorite
003
Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research

Favorite